Cargando…
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
Trimeric soluble forms of HIV gp140 envelope glycoproteins represent one of the closest molecular structures compared to native spikes present on intact virus particles. Trimeric soluble gp140 have been generated by several groups and such molecules have been shown to induce antibodies with neutrali...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729709/ https://www.ncbi.nlm.nih.gov/pubmed/23835244 http://dx.doi.org/10.1186/1479-5876-11-165 |
_version_ | 1782278991386771456 |
---|---|
author | Visciano, Maria Luisa Tagliamonte, Maria Stewart-Jones, Guillaume Heyndrickx, Leo Vanham, Guido Jansson, Marianne Fomsgaard, Anders Grevstad, Berit Ramaswamy, Meghna Buonaguro, Franco M Tornesello, Maria Lina Biswas, Priscilla Scarlatti, Gabriella Buonaguro, Luigi |
author_facet | Visciano, Maria Luisa Tagliamonte, Maria Stewart-Jones, Guillaume Heyndrickx, Leo Vanham, Guido Jansson, Marianne Fomsgaard, Anders Grevstad, Berit Ramaswamy, Meghna Buonaguro, Franco M Tornesello, Maria Lina Biswas, Priscilla Scarlatti, Gabriella Buonaguro, Luigi |
author_sort | Visciano, Maria Luisa |
collection | PubMed |
description | Trimeric soluble forms of HIV gp140 envelope glycoproteins represent one of the closest molecular structures compared to native spikes present on intact virus particles. Trimeric soluble gp140 have been generated by several groups and such molecules have been shown to induce antibodies with neutralizing activity against homologous and heterologous viruses. In the present study, we generated a recombinant trimeric soluble gp140, derived from a previously identified Ugandan A-clade HIV field isolate (gp140(94UG018)). Antibodies elicited in immunized rabbits show a broad binding pattern to HIV envelopes of different clades. An epitope mapping analysis reveals that, on average, the binding is mostly focused on the C1, C2, V3, V5 and C5 regions. Immune sera show neutralization activity to Tier 1 isolates of different clades, demonstrating cross clade neutralizing activity which needs to be further broadened by possible structural modifications of the clade A gp140(94UG018). Our results provide a rationale for the design and evaluation of immunogens and the clade A gp140(94UG018) shows promising characteristics for potential involvement in an effective HIV vaccine with broad activity. |
format | Online Article Text |
id | pubmed-3729709 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37297092013-08-01 Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate Visciano, Maria Luisa Tagliamonte, Maria Stewart-Jones, Guillaume Heyndrickx, Leo Vanham, Guido Jansson, Marianne Fomsgaard, Anders Grevstad, Berit Ramaswamy, Meghna Buonaguro, Franco M Tornesello, Maria Lina Biswas, Priscilla Scarlatti, Gabriella Buonaguro, Luigi J Transl Med Research Trimeric soluble forms of HIV gp140 envelope glycoproteins represent one of the closest molecular structures compared to native spikes present on intact virus particles. Trimeric soluble gp140 have been generated by several groups and such molecules have been shown to induce antibodies with neutralizing activity against homologous and heterologous viruses. In the present study, we generated a recombinant trimeric soluble gp140, derived from a previously identified Ugandan A-clade HIV field isolate (gp140(94UG018)). Antibodies elicited in immunized rabbits show a broad binding pattern to HIV envelopes of different clades. An epitope mapping analysis reveals that, on average, the binding is mostly focused on the C1, C2, V3, V5 and C5 regions. Immune sera show neutralization activity to Tier 1 isolates of different clades, demonstrating cross clade neutralizing activity which needs to be further broadened by possible structural modifications of the clade A gp140(94UG018). Our results provide a rationale for the design and evaluation of immunogens and the clade A gp140(94UG018) shows promising characteristics for potential involvement in an effective HIV vaccine with broad activity. BioMed Central 2013-07-08 /pmc/articles/PMC3729709/ /pubmed/23835244 http://dx.doi.org/10.1186/1479-5876-11-165 Text en Copyright © 2013 Visciano et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Visciano, Maria Luisa Tagliamonte, Maria Stewart-Jones, Guillaume Heyndrickx, Leo Vanham, Guido Jansson, Marianne Fomsgaard, Anders Grevstad, Berit Ramaswamy, Meghna Buonaguro, Franco M Tornesello, Maria Lina Biswas, Priscilla Scarlatti, Gabriella Buonaguro, Luigi Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate |
title | Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate |
title_full | Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate |
title_fullStr | Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate |
title_full_unstemmed | Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate |
title_short | Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate |
title_sort | characterization of humoral responses to soluble trimeric hiv gp140 from a clade a ugandan field isolate |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729709/ https://www.ncbi.nlm.nih.gov/pubmed/23835244 http://dx.doi.org/10.1186/1479-5876-11-165 |
work_keys_str_mv | AT viscianomarialuisa characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT tagliamontemaria characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT stewartjonesguillaume characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT heyndrickxleo characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT vanhamguido characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT janssonmarianne characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT fomsgaardanders characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT grevstadberit characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT ramaswamymeghna characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT buonagurofrancom characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT tornesellomarialina characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT biswaspriscilla characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT scarlattigabriella characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate AT buonaguroluigi characterizationofhumoralresponsestosolubletrimerichivgp140fromacladeaugandanfieldisolate |